SI2468885T1 - Transkripcijska nezvestoba, detekcija in njena uporaba - Google Patents

Transkripcijska nezvestoba, detekcija in njena uporaba

Info

Publication number
SI2468885T1
SI2468885T1 SI200731705T SI200731705T SI2468885T1 SI 2468885 T1 SI2468885 T1 SI 2468885T1 SI 200731705 T SI200731705 T SI 200731705T SI 200731705 T SI200731705 T SI 200731705T SI 2468885 T1 SI2468885 T1 SI 2468885T1
Authority
SI
Slovenia
Prior art keywords
infidelity
detection
transcription infidelity
design
disease
Prior art date
Application number
SI200731705T
Other languages
English (en)
Slovenian (sl)
Inventor
Bernard Bihain
Original Assignee
Genclis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genclis filed Critical Genclis
Publication of SI2468885T1 publication Critical patent/SI2468885T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Glass Compositions (AREA)
  • Pit Excavations, Shoring, Fill Or Stabilisation Of Slopes (AREA)
  • Peptides Or Proteins (AREA)
SI200731705T 2006-07-20 2007-07-20 Transkripcijska nezvestoba, detekcija in njena uporaba SI2468885T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06291176A EP1887088A1 (en) 2006-07-20 2006-07-20 Transcription infidelity, detection and uses thereof
EP11173357.2A EP2468885B1 (en) 2006-07-20 2007-07-20 Transcription infidelity, detection and uses thereof

Publications (1)

Publication Number Publication Date
SI2468885T1 true SI2468885T1 (sl) 2016-02-29

Family

ID=37496681

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200731705T SI2468885T1 (sl) 2006-07-20 2007-07-20 Transkripcijska nezvestoba, detekcija in njena uporaba
SI200730791T SI2046986T1 (sl) 2006-07-20 2007-07-20 Transkripcijska nezvestoba detekcija in njena uporaba

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200730791T SI2046986T1 (sl) 2006-07-20 2007-07-20 Transkripcijska nezvestoba detekcija in njena uporaba

Country Status (18)

Country Link
US (1) US8288091B2 (enExample)
EP (3) EP1887088A1 (enExample)
JP (1) JP5298013B2 (enExample)
KR (1) KR101502179B1 (enExample)
AT (1) ATE524565T1 (enExample)
AU (1) AU2007275068B2 (enExample)
BR (1) BRPI0714563B8 (enExample)
CA (1) CA2658305C (enExample)
CY (2) CY1112125T1 (enExample)
DK (2) DK2468885T3 (enExample)
ES (2) ES2553435T3 (enExample)
HU (1) HUE028135T2 (enExample)
IL (1) IL196600A0 (enExample)
PL (2) PL2468885T3 (enExample)
PT (2) PT2468885E (enExample)
SI (2) SI2468885T1 (enExample)
TR (1) TR201112295Y (enExample)
WO (1) WO2008009751A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2071334A1 (en) * 2007-12-14 2009-06-17 Transmedi SA Compositions and methods of detecting TIABS
EP2080812A1 (en) 2008-01-18 2009-07-22 Transmedi SA Compositions and methods of detecting post-stop peptides
EP2995688A1 (en) 2014-09-12 2016-03-16 Genclis Methods of prognosing and treating triple negative breast cancer
WO2017100789A1 (en) * 2015-12-11 2017-06-15 Expression Pathology, Inc. Srm/mrm assays
EP4148427A1 (en) 2016-03-18 2023-03-15 Genclis Molecular origin of allergy
WO2018187216A1 (en) * 2017-04-03 2018-10-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Expression cassettes and methods for detecting transcription errors
WO2019084158A1 (en) 2017-10-26 2019-05-02 Ultima Genomics, Inc. METHODS AND SYSTEMS FOR SEQUENCE CALL
WO2020185790A1 (en) 2019-03-10 2020-09-17 Ultima Genomics, Inc. Methods and systems for sequence calling
EP4010481A4 (en) 2019-08-09 2023-09-20 Nutcracker Therapeutics, Inc. MICROFLUIDIC DEVICE AND METHODS OF USE
KR102334576B1 (ko) * 2019-08-12 2021-12-07 한국생명공학연구원 융합 단백질 및 이를 포함하는 바이오 이미징용 조성물
EP4211268A4 (en) * 2020-09-10 2024-09-18 Ultima Genomics, Inc. SEQUENCE AND VARIANT CALLING METHODS AND SYSTEMS
WO2022108309A1 (ko) * 2020-11-18 2022-05-27 한양대학교 에리카산학협력단 인산화된 비멘틴의 과도한 생성을 차단하여 암을 예방 또는 치료하는 방법
EP4162948A1 (en) 2021-10-05 2023-04-12 Genclis Transcription infidelity derived chimeric immunogens and uses thereof
WO2023104904A2 (en) 2021-12-08 2023-06-15 Genclis The sars-cov-2 and variants use two independent cell receptors to replicate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4979330A (en) 1989-10-10 1990-12-25 Rorant Julius W Suction insect trap device
US6120992A (en) 1993-11-04 2000-09-19 Valigene Corporation Use of immobilized mismatch binding protein for detection of mutations and polymorphisms, and allele identification in a diseased human
AU2715601A (en) * 1999-12-03 2001-06-12 Koninklijke Nederlandse Akademie Van Wetenschappen Clearance of aberrant protein in correlation with disease
WO2002077286A1 (en) 2001-02-21 2002-10-03 Gene Check, Inc. Mutation detection using muts and reca
WO2006053061A2 (en) * 2004-11-10 2006-05-18 Kansas State University Research Foundation Porcine reproductive and respiratory syndrome virus receptor components and uses thereof

Also Published As

Publication number Publication date
EP2468885A2 (en) 2012-06-27
KR20090052861A (ko) 2009-05-26
EP2046986A2 (en) 2009-04-15
DK2046986T3 (da) 2012-01-02
ES2373428T3 (es) 2012-02-03
CY1112125T1 (el) 2015-11-04
BRPI0714563B8 (pt) 2021-05-25
AU2007275068B2 (en) 2013-06-06
EP2046986B1 (en) 2011-09-14
PT2468885E (pt) 2015-11-26
SI2046986T1 (sl) 2012-05-31
EP2468885B1 (en) 2015-08-19
WO2008009751A2 (en) 2008-01-24
CA2658305A1 (en) 2008-01-24
US20090317386A1 (en) 2009-12-24
US8288091B2 (en) 2012-10-16
PT2046986E (pt) 2011-12-29
PL2046986T3 (pl) 2012-02-29
DK2468885T3 (da) 2016-02-29
PL2468885T3 (pl) 2016-04-29
IL196600A0 (en) 2009-11-18
HK1128937A1 (en) 2009-11-13
JP2009544284A (ja) 2009-12-17
ATE524565T1 (de) 2011-09-15
CA2658305C (en) 2017-07-18
JP5298013B2 (ja) 2013-09-25
EP2468885A3 (en) 2012-08-29
BRPI0714563B1 (pt) 2019-07-02
BRPI0714563A2 (pt) 2015-04-14
TR201112295Y (tr) 2018-08-27
EP1887088A1 (en) 2008-02-13
CY1116939T1 (el) 2017-04-05
HUE028135T2 (en) 2016-12-28
ES2553435T3 (es) 2015-12-09
KR101502179B1 (ko) 2015-03-12
WO2008009751A3 (en) 2008-07-31
AU2007275068A1 (en) 2008-01-24

Similar Documents

Publication Publication Date Title
IL196600A0 (en) Transcription infidelity, detection and uses thereof
WO2010082944A3 (en) Systems and methods for imaging changes in tissue
WO2008088849A3 (en) Inflammation treatment, detection and monitoring via trem-1
WO2005103281A3 (en) Platelet biomarkers for the detection of disease
MX343327B (es) Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa.
HRP20130618T1 (en) Methods of using mirna for detection of in vivo cell death
WO2009102895A3 (en) Method to predict response to pharmacological chaperone treatment of diseases
WO2010054386A3 (en) Methods, compositions, and devices utilizing microrna to determine physiological conditions
EP3070474A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
BRPI0914020A2 (pt) método para detecção e/ou o diagnóstico de uma ou mais causas de distúrbio do ritmo do coração, sistema para a detecção e/ou o tratamento de uma ou mais causas de um distúrbio do ritmo do coração, método para o tratamento de distúrbio do ritmo do coração, dispositivo sensor ajustável para detectar distúrbios do ritmo do coração, método para a detecção e/ou o diagnóstico de uma ou mais causas de um distúrbio do ritmo biológico, sistema para a detecção e/ou o tratamento de uma ou mais causas de um distúrbio do ritmo biológico e método para o tratamento de um distúrbio do ritmo biológico
WO2006073682A3 (en) Diagnostic test
EP2857522A3 (en) Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy
WO2007110623A3 (en) Screening method
WO2007136617A3 (en) Endothelial-monocyte activating polypeptide ii, a biomarker for use in diagnosis of brain injury
WO2011052906A3 (en) Use of eif3m for the diagnosis and treatment of cancer
NO20074610L (no) Fremgangsmate for a bestemme mottakeligheten til CHK1 inhibitorer
WO2009001545A1 (ja) 移植片対宿主疾患の検査および治療方法
JP2010256190A5 (enExample)
WO2009073575A3 (en) Methods for treating induced cellular proliferative disorders
WO2008060400A3 (en) Sirtuin polymorphisms and methods of use thereof
WO2009087689A3 (en) Novel primers for identification of astrocytoma, it's grades and glioblastoma prognosis
WO2005089310A3 (en) Breath test for oral malodor
WO2007067719A3 (en) Diagnosing human diseases by detecting dna methylation changes
WO2006074450A3 (en) Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
WO2008012692A3 (en) Assay for efficacy of histone deacetylase inhibitors